Format

Send to

Choose Destination
Indian J Urol. 2008 Oct;24(4):526-31. doi: 10.4103/0970-1591.44262.

Ureteroscopic management of upper tract transitional cell carcinoma and ureteropelvic obstruction.

Author information

1
Glickman Urological and Kidney Institute, The Cleveland Clinic Foundation, Cleveland, Ohio and Department of Urology, University of Minnesota, USA.

Abstract

INTRODUCTION:

Technological advances have increased the application of the endoscopic management of upper tract transitional cell carcinoma (TCC) and ureteropelvic junction obstruction (UPJO).

MATERIALS AND METHODS:

Published, peer-reviewed articles on endoscopic treatment of upper tract TCC and UPJO were identified using the MEDLINE database.

RESULTS:

Although nephroureterectomy remains the gold standard for upper tract TCC treatment, low-grade, low-stage and small tumors, especially in patients with solitary kidneys or poor renal function can be managed with encouraging success rates, despite the considerable recurrence rate. Endoscopic alternatives to pyeloplasty for UPJO can be used especially in cases with absence of crossing vessels, stricture length less than 1.5 cm, severe hydronephrosis and renal function less than 30%.

CONCLUSION:

Proper patient selection is critical for the successful endoscopic management of treatment of upper tract TCC and UPJO.

KEYWORDS:

Upper tract transitional cell carcinoma; ureteropelvic obstruction; ureteroscopy

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center